Could Spinal Epidural Lipomatosis Be the Hallmark of Metabolic Syndrome on the Spine? A Literature Review with Emphasis on Etiology.
Valerio D'AgostinoMiriana Rosaria PetreraGiuseppe TedescoValerio PipolaFederico PontiPaolo SpinnatoPublished in: Diagnostics (Basel, Switzerland) (2023)
Spinal epidural lipomatosis is defined by an excessive amount of epidural fat in the spinal canal, usually in the lumbosacral tract: a well-known cause of lumbar pain and spinal stenosis with a possible wide range of neurological symptoms. Recent research data reveal that, nowadays, obesity has become the main cause of spinal epidural lipomatosis. Moreover, this condition was recently recognized as a previously unknown manifestation of metabolic syndrome. Radiological studies (CT and MRI) are the only tools that are able to diagnose the disease non-invasively. Indeed, radiologists play a key role in disease recognition, with subsequent possible implications on patients' systemic health assessments. Despite its clinical importance, the condition is still underreported and neglected. The current literature review summarizes all the main etiologies of spinal epidural lipomatosis, particularly regarding its linkage with metabolic syndrome. An overview of disease characteristics from diagnosis to treatment strategies is also provided.
Keyphrases
- spinal cord
- metabolic syndrome
- neuropathic pain
- spinal cord injury
- insulin resistance
- uric acid
- healthcare
- end stage renal disease
- adipose tissue
- computed tomography
- chronic kidney disease
- genome wide
- newly diagnosed
- type diabetes
- contrast enhanced
- ejection fraction
- physical activity
- artificial intelligence
- dna methylation
- minimally invasive
- pain management
- health information
- positron emission tomography
- depressive symptoms
- prognostic factors
- cardiovascular disease
- human immunodeficiency virus
- drug induced
- sleep quality
- health promotion
- diffusion weighted imaging
- hepatitis c virus
- deep learning